Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RetinSphere
- Development stage
- Unknown
- Lead developer
- Cantabria Labs
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
RetinSphere® is a proprietary topical retinoid technology developed by Industrial Farmacéutica Cantabria (Cantabria Labs) for use in cosmeceutical and dermatological skincare. The technology consists of a synergistic blend of two stable retinoids: hydroxypinacolone retinoate, a retinoic acid ester that binds directly to retinoid receptors without metabolic conversion, and stabilized encapsulated retinol, which provides a sustained release for prolonged activity. RetinSphere® is designed to deliver the skin-renewing and anti-aging benefits of traditional retinoic acid—such as improved texture, reduced hyperpigmentation, and collagen stimulation—while significantly improving tolerability and minimizing the irritation typically associated with potent retinoids. It is incorporated into several Cantabria Labs product lines, including Endocare (anti-aging), Biretix (acne-prone skin), and Neoretin (hyperpigmentation), to address various dermatologic cosmetic concerns.
- Brand names
- RetinSphere
- Other names
- RetinSphere TechnologyRETINSPHERE
02
Targets
RXRA (Retinoid X receptor alpha)RARA (Retinoic acid receptor alpha)
Beyond the preview
Go deeper on RetinSphere.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RetinSphere.